“E-Health Law” in Germany
par Dr. Wolfgang Rehmann
Intellectual Property in the Life Sciences, in review
par Dr Paul England
Supreme Court ruling on penalty clauses: consequences for bad leaver provisions
par Debbie Cloake
Strategic considerations - why opt-out or why not?
par Dr. Anja Lunze, LL.M.
Using intellectual property protection
par Colin McCall
Mobile medical apps in Europe
par Thanos Rammos, LL.M.